| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 15, 2005
Accepted on November 1, 2005
From the Petit Institute for Bioengineering and Bioscience (J.T.B., T.J., R.M.N.) and Woodruff School of Mechanical Engineering (J.T.B., R.M.N.), Georgia Institute of Technology, Atlanta; Coulter Department of Biomedical Engineering (S.T., G.S., H.J.), and Division of Cardiology, Georgia Tech and Emory University, Atlanta; and Cardiovascular Developmental Biology Center (J.T.B., D.T.), Children’s Research Institute, Medical University of South Carolina, Charleston.
* To whom correspondence should be addressed. E-mail: Robert.nerem{at}ibb.gatech.edu.
Objective--The similarities between valvular and vascular lesions suggest pathological initiation mediated through endothelium, but the role of hemodynamics in valvular endothelial biology is poorly understood.
Methods and Results--Monolayers of porcine aortic endothelial cells (PAECs) or porcine aortic valve endothelial cells (PAVECs) were exposed to 20 dyne/cm2 steady laminar shear stress for 48 hours, with static cultures serving as controls. Multiple microarray comparisons were made using RNA from sheared and control batches of both cell types. More than 400 genes were significantly differentially expressed in each comparison group. The resulting profiles were validated at the transcription and protein level and expression patterns confirmed in vivo by immunohistochemistry. PAVECs were found to be less intrinsically inflammatory than PAECs, but both cell types expressed similar antioxidant and antiinflammatory genes in response to shear stress. PAVECs expressed more genes associated with chondrogenesis, whereas PAECs expressed osteogenic genes, and shear stress had a protective effect against calcification.
Conclusions--Transcriptional differences between PAVECs and PAECs highlight the valvular endothelial cell as a distinct organ system and suggest more attention needs to be given to valvular cells to further our understanding of similarities and differences between valvular and vascular pathology.
This article has been cited by other articles:
![]() |
A. C. Liu, V. R. Joag, and A. I. Gotlieb The Emerging Role of Valve Interstitial Cell Phenotypes in Regulating Heart Valve Pathobiology Am. J. Pathol., November 1, 2007; 171(5): 1407 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chang, D. Weiss, J. Suo, J. D. Vega, D. Giddens, W. R. Taylor, and H. Jo Bone Morphogenic Protein Antagonists Are Coexpressed With Bone Morphogenic Protein 4 in Endothelial Cells Exposed to Unstable Flow In Vitro in Mouse Aortas and in Human Coronary Arteries: Role of Bone Morphogenic Protein Antagonists in Inflammation and Atherosclerosis Circulation, September 11, 2007; 116(11): 1258 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Keller New Insights Into the Developmental Biomechanics of the Atrioventricular Valves Circ. Res., May 25, 2007; 100(10): 1399 - 1401. [Full Text] [PDF] |
||||
![]() |
J. T. Butcher, T. C. McQuinn, D. Sedmera, D. Turner, and R. R. Markwald Transitions in Early Embryonic Atrioventricular Valvular Function Correspond With Changes in Cushion Biomechanics That Are Predictable by Tissue Composition Circ. Res., May 25, 2007; 100(10): 1503 - 1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Csiszar, N. Labinskyy, K. E. Smith, A. Rivera, E. N.T.P. Bakker, H. Jo, J. Gardner, Z. Orosz, and Z. Ungvari Downregulation of Bone Morphogenetic Protein 4 Expression in Coronary Arterial Endothelial Cells: Role of Shear Stress and the cAMP/Protein Kinase A Pathway Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 776 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Aird Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds Circ. Res., February 2, 2007; 100(2): 174 - 190. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |